Pricing Log in Create free account

Cocrystal Pharma, Inc. (COCP) vs Pasithea Therapeutics Corp. (KTTA)

Cocrystal Pharma, Inc. and Pasithea Therapeutics Corp. are both Biotechnology companies. Cocrystal Pharma, Inc. is the larger, with a market value of $19.3M against $17.4M — 1.1× the size. Pasithea Therapeutics Corp. has the higher net margin (0.00% vs −747.8%) and the lower return on invested capital (−367.5% vs 0.00%). Across the 15 metrics below, Pasithea Therapeutics Corp. leads on 9 and Cocrystal Pharma, Inc. on 6.

Valuation

Metric COCP KTTA Biotechnology median
P/E n/m n/m 10.60
P/S 10.69 38.26 9.40
P/B 13.60 0.37 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 1.17 0.66
EV/Sales 9.00 (55.79) 9.02
Earnings yield (73.79%) (254.86%) (32.88%)
Free cash flow yield (56.09%) (94.76%) (23.13%)

Profitability

Metric COCP KTTA Biotechnology median
Gross margin 9.10% 0.00% 68.51%
Operating margin (760.72%) 0.00% 0.00%
Net margin (747.78%) 0.00% 0.00%
Free cash flow margin (598.50%) 0.00% 0.00%
Return on equity (311.68%) (65.49%) (51.96%)
Return on assets (151.10%) (61.97%) (46.06%)
Return on invested capital 0.00% (367.46%) 0.00%

Growth

Metric COCP KTTA Biotechnology median
Revenue growth (TTM) (30.38%) — 6.76%
EPS growth (last fiscal year) 54.65% 77.07% 29.88%
Revenue growth, 5-year CAGR (33.30%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COCP KTTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.24 26.25 4.97
Net debt to EBITDA 0.82 2.74 1.01

Dividend

Metric COCP KTTA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric COCP KTTA Biotechnology median
Market cap 19.27m 17.38m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack